Sep 2026· Journal of Endovascular Therapy· pp.
15266028261485124
· 0 citations· 11 references
Medicine
TL;DR
Stent graft placement provided durable patency at the target venous anastomosis, however, the primary site of access failure shifted to the intra-arteriovenous graft segment, driving high reintervention rates, and these findings highlight the need for therapeutic strategies targeting the graft body to reduce the overall intervention burden.
Abstract
Objective
Stent graft placement is an established treatment for arteriovenous graft venous anastomotic stenosis. However, maintaining secondary patency often requires frequent reinterventions, burdening patients, and health care systems. This study evaluated the 2-year outcomes of stent graft placement, focusing specifically on the frequency and anatomical distribution of subsequent reinterventions.
Methods
This 2-year analysis of a prospective, multicenter postmarket surveillance study in Japan involved 103 patients (105 lesions) treated with the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface for arteriovenous graft venous anastomotic stenosis or thrombosis. Primary endpoints were target-lesion primary patency (TLPP) and access circuit primary patency (ACPP). Reintervention topology across 5 anatomical zones was analyzed.
Results
At 2 years, TLPP was 30.5% (95% confidence interval [CI]: 21.0, 40.5), whereas ACPP was lower at 12.4% (95% CI: 6.4, 20.7). Secondary patency was 83.5% (95% CI: 73.6, 90.0) for both measures. A total of 242 reinterventions were performed, with a mean cumulative number of 1.76 per patient at 2 years. Topological analysis revealed that the intra-arteriovenous graft segment was the most frequent site of failure (134 events), followed by stent graft outflow (66 events). Failure at the intra-stent graft was rare (2 events). The median time to first reintervention was shortest for intra-arteriovenous graft lesions (205 days).
Conclusions
Stent graft placement provided durable patency at the target venous anastomosis. However, the primary site of access failure shifted to the intra-arteriovenous graft segment, driving high reintervention rates. These findings highlight the need for therapeutic strategies targeting the graft body to reduce the overall intervention burden.Clinical ImpactThis prospective multicenter study maps, over two years, where reinterventions actually occur after stent graft placement for arteriovenous graft outflow stenosis. Although the treated venous anastomosis remained durable, access circuit primary patency fell to 12.4%, because failure migrated to the graft body, which accounted for 134 reinterventions at a median of 205 days. This reframes success for clinicians: treating the target lesion does not preserve the circuit. Surveillance after stent grafting should anticipate early intra-graft restenosis, and efforts to reduce the intervention burden-cannulation strategy, graft materials, adjunctive devices-should target the graft body rather than the anastomosis.
Cross-elbow stenting was technically feasible and provided favorable short- to mid-term patency without device-related complications, supporting its use as a salvage option for selected refractory AVF lesions and CTOs.
BACKGROUND
Endovascular repair with covered stent-grafts offers a prompt and effective strategy to manage lower-extremity arterial trauma and catheterization-related iatrogenic vascular complications. However, long-term durability and late complication profiles of covered stent-grafts in the femoral segments remain poo...
Ö. Ateş, O. Taydaş, Murat Canyiğit· Annals of Vascular Surgery· 0 citations
OBJECTIVES
To evaluate technical and clinical success rates and complications of stent-grafting for hepatic artery bleeding or pseudoaneurysms.
MATERIALS AND METHODS
This single-centre retrospective study consecutively included 58 patients who underwent attempted stent-grafting for hepatic artery bleeding (n = 40) or...
R. Mathy, Daniel Da Florencia Ricardo, Sam Sedaghat et al.· European Radiology· 0 citations
In this selected retrospective cohort, endovascular stenting was associated with shorter hospitalization and fewer systemic complications than bypass surgery and should be interpreted cautiously because of the small sample size, treatment-selection bias, and differences in follow-up duration.
Peng-Chao Duan, Yu-Han Qi, Ji-Chun Zhao et al.· Frontiers in Cardiovascular...· 0 citations
BMS and CS showed no significant differences in TRAS outcomes, which suggests that covered stents may be a reasonable option when heavy calcification, a friable wall or mural thrombus raise concern for embolisation or rupture, while bare-metal stents remain appropriate for most lesions.
A. Discalzi, Enrico Sanna, M. Ruffino et al.· Journal of Endovascular Ther...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.